Literature DB >> 33044428

Ex Vivo Lung Perfusion: Current Achievements and Future Directions.

Nikhil K Prasad1, Chetan Pasrija1, Tara Talaie1, Alexander S Krupnick1, Yunge Zhao1, Christine L Lau1.   

Abstract

There is a severe shortage in the availability of donor organs for lung transplantation. Novel strategies are needed to optimize usage of available organs to address the growing global needs. Ex vivo lung perfusion has emerged as a powerful tool for the assessment, rehabilitation, and optimization of donor lungs before transplantation. In this review, we discuss the history of ex vivo lung perfusion, current evidence on its use for standard and extended criteria donors, and consider the exciting future opportunities that this technology provides for lung transplantation.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33044428      PMCID: PMC8792510          DOI: 10.1097/TP.0000000000003483

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  72 in total

1.  Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours.

Authors:  Simon Becker; Jasmin Steinmeyer; Murat Avsar; Klaus Höffler; Jawad Salman; Axel Haverich; Gregor Warnecke; Matthias Ochs; Anke Schnapper
Journal:  Transpl Int       Date:  2015-08-27       Impact factor: 3.782

2.  Bronchodilator Inhalation During Ex Vivo Lung Perfusion Improves Posttransplant Graft Function After Warm Ischemia.

Authors:  Kyoko Hijiya; Toyofumi F Chen-Yoshikawa; Takeshi Kondo; Hideki Motoyama; Akihiro Ohsumi; Daisuke Nakajima; Jin Sakamoto; Keiji Ohata; Mamoru Takahashi; Satona Tanaka; Ei Miyamoto; Akihiro Aoyama; Hiroshi Date
Journal:  Ann Thorac Surg       Date:  2016-10-10       Impact factor: 4.330

3.  Ex vivo evaluation of stored lungs.

Authors:  D W Jirsch; R L Fisk; C M Couves
Journal:  Ann Thorac Surg       Date:  1970-08       Impact factor: 4.330

Review 4.  Breathing lung transplantation with the Organ Care System (OCS) Lung: lessons learned and future implications.

Authors:  William Lightle; Daoud Daoud; Gabriel Loor
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

5.  Prone Positioning During Ex Vivo Lung Perfusion Influences Regional Edema Accumulation.

Authors:  Sofie Ordies; Anna E Frick; Sandra Claes; Dominique Schols; Stijn E Verleden; Dirk E Van Raemdonck; Arne P Neyrinck
Journal:  J Surg Res       Date:  2019-03-19       Impact factor: 2.192

Review 6.  Mechanisms of lung ischemia-reperfusion injury.

Authors:  Victor E Laubach; Ashish K Sharma
Journal:  Curr Opin Organ Transplant       Date:  2016-06       Impact factor: 2.640

7.  Ex Vivo Perfusion With Adenosine A2A Receptor Agonist Enhances Rehabilitation of Murine Donor Lungs After Circulatory Death.

Authors:  Matthew L Stone; Ashish K Sharma; Valeria R Mas; Ricardo C Gehrau; Daniel P Mulloy; Yunge Zhao; Christine L Lau; Irving L Kron; Mary E Huerter; Victor E Laubach
Journal:  Transplantation       Date:  2015-12       Impact factor: 4.939

Review 8.  EVLP: Ready for Prime Time?

Authors:  Gabriel Loor
Journal:  Semin Thorac Cardiovasc Surg       Date:  2018-06-21

9.  The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.

Authors:  Anders S I Andreasson; Lee A Borthwick; Colin Gillespie; Kasim Jiwa; Jonathan Scott; Paul Henderson; Jonny Mayes; Rosalba Romano; Marius Roman; Simi Ali; James E Fildes; Nandor Marczin; John H Dark; Andrew J Fisher
Journal:  J Heart Lung Transplant       Date:  2017-05-12       Impact factor: 10.247

10.  Treatment of infected lungs by ex vivo perfusion with high dose antibiotics and autotransplantation: A pilot study in pigs.

Authors:  Norman Zinne; Marcus Krueger; Doris Hoeltig; Burkhard Tuemmler; Erin C Boyle; Christian Biancosino; Klaus Hoeffler; Peter Braubach; Taufiek K Rajab; Anatol Ciubotaru; Judith Rohde; Karl-Heinz Waldmann; Axel Haverich
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

View more
  2 in total

1.  Ex Vivo Lung Perfusion with β-Nicotinamide Adenine Dinucleotide (NAD+) Improves Ischemic Lung Function.

Authors:  Jonas Peter Ehrsam; Jin Chen; Hector Rodriguez Cetina Biefer; Isabelle Opitz; Stephan Arni; Ilhan Inci
Journal:  Antioxidants (Basel)       Date:  2022-04-26

Review 2.  Novel approaches for long-term lung transplant survival.

Authors:  Cynthia L Miller; Jane M O; James S Allan; Joren C Madsen
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.